SOPHiA GENETICS S.A.
SOPHNASDAQHealthcare● Active
$5.28
+$0.28(+5.60%)
Market Cap$378410736
P/E Ratio—
52W High$5.7
52W Low$2.59
SOPHiA GENETICS S.A. (SOPH) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SOPH · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $77.27M | $65.17M | $62.37M | $47.56M | $40.45M |
| Cost of Revenue | $29.46M | $21.24M | $19.46M | $16.31M | $15.23M |
| Gross Profit | $47.81M | $43.94M | $42.91M | $31.25M | $25.22M |
| Gross Margin %(computed) | 61.88% | 67.42% | 68.80% | 65.71% | 62.35% |
| Operating Expenses | |||||
| R&D Expenses | $33.57M | $34.37M | $36.97M | $35.37M | $26.58M |
| G&A Expenses | $0.00M | $46.95M | $53.30M | $55.82M | $41.51M |
| Total Operating Expenses | $118.74M | $110.50M | $117.74M | $119.08M | $96.71M |
| Operating Income | ($70.92M) | ($66.57M) | ($74.83M) | ($87.82M) | ($71.49M) |
| Operating Margin %(computed) | -91.79% | -102.14% | -119.97% | -184.66% | -176.73% |
| Interest Income | $1.87M | $3.36M | $4.55M | $1.32M | $0.02M |
| Interest Expense | $4.55M | $1.91M | $0.59M | $0.64M | $0.66M |
| Income Before Tax | ($78.49M) | ($61.27M) | ($78.50M) | ($87.58M) | ($73.51M) |
| Income Tax Expense | $0.51M | $1.22M | $0.49M | ($0.14M) | $0.17M |
| Net Income | ($79.00M) | ($62.49M) | ($78.98M) | ($87.45M) | ($73.67M) |
| Net Margin %(computed) | -102.24% | -95.89% | -126.63% | -183.87% | -182.14% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.17 | $-0.95 | $-1.22 | $-1.36 | $-1.33 |
| Wtd Avg Shares | 67.54M | 65.78M | 64.75M | 64.10M | 55.30M |
| EBITDA | ($61.40M) | ($50.76M) | ($69.57M) | ($81.38M) | ($69.24M) |
| EBITDA Margin %(computed) | -79.46% | -77.89% | -111.54% | -171.10% | -171.17% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more SOPHiA GENETICS S.A. data
About SOPHiA GENETICS S.A. (SOPH) Income Statement
SOPHiA GENETICS S.A. (SOPH) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, SOPH reported revenue of $0.08B, gross profit of $0.05B (gross margin 61.88%), and net income of ($0.08B) — a net profit margin of -102.24%.
Frequently asked questions
SOPH · 4 questionsSOPHiA GENETICS S.A. (SOPH) reported revenue of $0.08B for 2025, up 18.6% year-over-year.
SOPH revenueSOPH salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08